Insurtech company Turtlemint is raising ₹397.2 crore from major investors ahead of the much-anticipated IPO. The company sold shares at ₹152 each, the highest price that it wanted to charge, which signifies that investors are buying into its growth story.
The pre‑IPO fundraising round was attended by ICICI Prudential, Mirae Asset, BNP Paribas, Edelweiss, Bank of India, Bajaj Life Insurance and Axis Max Life Insurance. Their participation underscores the growing appeal of India’s insurtech sector which is rapidly growing as digital adoption reshapes the insurance landscape.
Turtlemint will raise ₹883 crore through its IPO in total. Of the total value of IPO, ₹221 crore will be raised by existing shareholders who will sell a part of their stake and the rest will be raised through fresh issue of shares. The IPO will open on Friday.
Turtlemint was founded with the notion of simplifying insurance for consumers with a distribution network and digital platform to connect customers to tailored insurance solutions in mind. If it can attract top‑tier investors prior to its IPO, it is an indication of confidence in its business model and growth trajectory.
In a related development, healthcare investment firm HealthQuad, backed by Quadria Group, has secured ₹550 crore for its third fund. This is more than a third of its ₹1,700 crore target and is indicative of investors’ appetite for healthcare opportunities in India.
All of these fundraising activities highlight the buoyant situation in India’s capital markets, where insurtech and healthcare sectors are seeing huge investor interest. As Turtlemint gets ready to go public, market observers will be interested in how well it does and how it will be useful for other future listings in the future.
